1. Home
  2. NWPX vs COAG Comparison

NWPX vs COAG Comparison

Compare NWPX & COAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Pipe Company

NWPX

Northwest Pipe Company

N/A

Current Price

$113.88

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Logo Hemab Therapeutics Holdings Inc. Common Stock

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$52.32

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWPX
COAG
Founded
1966
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
NWPX
COAG
Price
$113.88
$52.32
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$70.00
N/A
AVG Volume (30 Days)
190.5K
414.6K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
4.71
N/A
EPS
2.69
N/A
Revenue
$526,003,000.00
N/A
Revenue This Year
$6.98
N/A
Revenue Next Year
$3.30
N/A
P/E Ratio
$41.55
N/A
Revenue Growth
6.79
N/A
52 Week Low
$49.45
$27.47
52 Week High
$152.03
$53.61

Technical Indicators

Market Signals
Indicator
NWPX
COAG
Relative Strength Index (RSI) 33.96 64.67
Support Level $105.00 $42.65
Resistance Level $114.27 N/A
Average True Range (ATR) 6.81 4.41
MACD -1.74 0.01
Stochastic Oscillator 11.04 87.31

Price Performance

Historical Comparison
NWPX
COAG

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products, and operates in two segments, Water Transmission Systems (WTS), operating as the Northwest Pipe Company brand, and Precast Infrastructure and Engineered Systems (Precast), which includes the brands NWPX Geneva and NWPX Park. WTS manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. Precast manufactures stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including reinforced concrete pipe (RCP), manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration units, and other environmental and engineered solutions.

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Share on Social Networks: